Aurora Cannabis Inc. (the “Company” or “Aurora”) (ACB) (ACB) ( Frankfurt : 21P; WKN: A1C4WM) and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI; OTCQX: RDDTF), introduced as we speak that Aurora has taken supply of Radient’s first business batch of completed hashish derivatives, from Radient’s proprietary extraction platform. With this primary batch, Radient has confirmed its enhanced capacity to supply cannabinoid derivatives at business scale, and will proceed to scale up manufacturing at Radient’s hashish facility in Edmonton , reaching an anticipated eventual annual throughput of roughly 300,000 kg of hashish biomass at this single location.
The partnership between Radient and Aurora was established in 2017 after the completion of a Research Joint Venture that validated Radient’s MAPTM extraction know-how was succesful of superior cannabinoid extraction at business scale. For Aurora, the connection with Radient varieties an necessary element of its by-product product technique, offering a larger return on the biomass allotted for extraction, beneficial value benefits, and considerably elevated extraction capability.
– Read the complete article at Yahoo News.